i
v is now over a century since the first description of intracranial pressure (ICP) measurement by E. Leyden in Germany, ~~ and over 30 years from the introduction of the technique into clinical practice. 7,'~ In the last 20 years the indications for ICP monitoring have increased to include head injury, j2"~7 subarachnoid and intracranial hemorrhage, 22 brain tumors, 2 hydrocephalus, 6 hypoxic brain damager and encephalitis. 3
ICP Monitoring Techniques
There are three main methods of measuring ICP, depending on the site of sensor placement: extradural, surface subarachnoid and subdural, and ventricular fluid pressure.
Extradural Monitoring
For extradural pressure monitoring, either the sensor is placed in direct apposition to the dura or the signal is transmitted to an extracranial sensor using a fluidfilled extradural screw. 43j The method affords the advantages of relatively easy placement and a low incidence of serious infection, as the dura remains intact. Nevertheless, major disadvantages are: signal damping, problems of sensor plate dura interrelationships, 5,24 and a tendency to over-read when compared to ventricular pressure. 425"26 In addition, the method does not allow assessment of intracranial compliance.
Surface Subarachnoid and Subdural Monitoring
In the second method, the ICP is transmitted via a fluid column to a sensor using a subarachnoid catheter or extradural screw placed in the subdural or subarachnoid spaces. 3234 The main advantages are ease of placement, avoidance of brain puncture, and the ability to obtain some information about intracranial compliance. Disadvantages include the tendency of the system to obstruct, or to leak cerebrospinal fluid (CSF), especially with the catheter, and the potential risk of meningitis owing to the dural breech. In addition, Mendelow, et al., ~5 have reported that both the Leeds and Richmond screws tend to under-read in the subdural space at ICP values above 20 mm Hg. Recently, the possibility has been raised that the ICP recorded in the surface subarachnoid space may vary with the site of measurement in patients with unilateral pathology. 33
Ventricular Fluid Pressure
The ventricular fluid pressure method involves the insertion of a catheter into the frontal horn of the lateral ventricle with connection by fluid fine to an external sensor. The method has the advantage of high-quality recordings and allows CSF drainage 8 and pressure volume analysisfl j3"~8"27 However, there are several disadvantages. Placement is sometimes difficult, particularly where there is ventricular distortion, and catheter inser- Table 2 . Where more than one category is given, the device functioned differently on separate days of testing. Assessment of infusion test is defined in the text. S = satisfactory; PS = partially satisfactory; US = unsatisfactory.
"~ Measurements prior to coning if it occurred.
FIG. 2.
Intracranial pressure (ICP) record during a normal infusion test; repeated 2-minute infusions of the device (periods 1 and 2) caused no change in the ICP trace. Following infusion 2, flushing the device failed to alter the ICP trace. Subsequent 2-minute infusions (periods 3 and 4) produce no alteration in the ICP trace. The 2-to 3-mm decrease after flushing is due to repositioning of the transducer. The Leeds Screw Device D u r i n g the last 5 years ICP m e a s u r e m e n t has been increasingly used as a guide to m a n a g e m e n t o f severe head injury. R e c e n t studies indicate that ICP m o n i t o ring m a y contribute to early assessment o f prognosis. 14"172~ In view o f the reliance n o w being placed o n ICP data, it is i m p o r t a n t to ensure that the inform a t i o n obtained f r o m these m e a s u r e m e n t t e c h n i q u e s is accurate.
In Leeds a screw device ( Fig. 1 ) has been in use for the past 10 years to m o n i t o r ICP in severely headinjured patients. 4'2~ At first the device was placed extradurally, but for the past 6 years the u n d e r l y i n g d u r a has been incised so as to m e a s u r e surface s u b a r a c h n o i d pressure, which yields high-quality recordings. Nevertheless, it is e v i d e n t from o u r experience and that o f M e n d e l o w , et al., Is that the Leeds device m a y sometimes under-read, due to partial obstruction. If m e a ningful data are to be obtained and the correct conclusions d r a w n c o n c e r n i n g a p p a r e n t changes in ICP and intracranial c o m p l i a n c e (based on pulse or respiratory wave a m p l i t u d e zv'zs) it is essential to k n o w the limita- tions of the system and to be able to recognize and correct problems when they arise.
A study of the Leeds bolt has therefore been undertaken to determine the incidence of day-to-day problems with this ICP monitoring technique in severely head-injured patients.
Clinical Material and Methods
This study included 18 patients with severe head injury who underwent subarachnoid pressure monitoring with the Leeds ICP device (Table l) . The mean time from head injury to the commencement of ICP monitoring was 8.6 hours and ranged from 3 to 35 hours. The average duration of monitoring was 5.7 days, ranging from 12 hours to 12 days.
After a 2-minute control reading of ICP, a slow infusion of normal saline (0.02 ml/min for 2 minutes) was administered through the device into the subarachnoid space, using a Harvard pump connected by catheter to a three-way tap, which also communicated with a pressure transducer.* The pressure measured was displayed on a chart recorder with a paper speed of 30 mm/min, and the effect of the infusion was observed * Harvard pump manufactured by Harvard Apparatus Co., 150 Dover Road, Millis, Massachusetts. Elcomatic EM 750 pressure transducer manufactured by Elcomatic, Kirktonfield Road, Neilston, Glasgow, Scotland. on both the mean ICP (taken as the mid-point of the trace width) and the amplitude of the recording (including both pulse and respiratory components). After this infusion, recording of ICP was continued for a further 2 minutes. The test was then repeated to confirm reproducibility. After these two infusion tests, 0.2 ml normal saline was rapidly injected up to four times until CSF leaked from the tap. Any saline used to flush the device was allowed to drain prior to continuing ICP recording. The effect on ICP and amplitude was observed. If, after four flushes, no CSF leak was obtained, no further fluid was injected in order to avoid any risk of inducing ICP waves. 3~ Following a 2-minute period of stabilization (ICP and amplitude may over-read immediately after flushing), the mean ICP and trace amplitudes were noted and two further infusion tests performed as outlined above.
The results of the above tests were classified into six categories, as described in Table 2 . These categories were: 1) normal (Fig. 2) ; 2) partial obstruction of the device (Fig. 3): 3) intracranial pocketing around the device; 4) plateauing (Fig. 4) ; 5) leaking; and 6) overreading.
The measurements from 69 infusion studies on separate days in 18 patients were combined to allow an overall appraisal of the function of the Leeds ICP device. Results were considered satisfactory, where the infusion test led to no change in mean ICP or amplitude between ventricular and subarachnoid space pressures was studied before and after infusion and flushing, The CSF obtained from the Leeds device was cultured in 11 of the 18 patients. No culture revealed bacterial growth after 4 days' incubation.
Differences between groups were tested for statistical significance using Student's unpaired t-test, and a p value of less than 0.05 was considered significant. of ICP pulsations; partially satisfactory, where the infusion test revealed an improper reading that was correctable with flushing; or unsatisfactory, where repeated flushing was unable to produce a normal infusion test, as defined on Table 2 . In addition, the performance category of the device was considered in relation to the correct ICP as evidenced by the post-flush infusion value and the duration of monitoring. Finally, the ICP records of patients with clinical evidence of mid-brain coning were studied to see whether the moment of coning could be detected from the ICP tracing without the aid of infusion or post-flush testing.
The values for mean ICP obtained from normally functioning devices (those in Category 1) were compared with ICP recordings from malfunctioning devices. In these comparisons the true ICP was taken to be the value obtained during a normal infusion test following flushing of the device.
In one patient (Case 8), a ventricular catheter was inserted during ICP monitoring to treat posttraumatic internal hydrocephalus. In this patient, the relationship
Results
A total of 69 infusion tests were made on the 18 devices on separate days of patient monitoring, excluding infusion tests to ascertain if coning had occurred. Of these, 33 were classified as normal (that is, as reading the true ICP). In 31 of the remaining 36 tests, it proved possible to identify and remedy the problem. The remaining five tests related to two devices, of which one showed intracranial pocketing (in Case 10) and the other leaked (in Case 5). Neither o f these devices could be rectified by flushing alone, but the leaking device was corrected by tightening the contact with the skull.
Seven of the devices were considered to have functioned satisfactorily as defined above (prior to coning if this occurred), and 10 were considered partially satisfactory. The remaining device showed recurrent irremediable pocketing and was considered unsatisfactory. During treatment and ICP monitoring, three of the 18 patients in the series suffered midbrain coning. In two cases the time of coning could be ascertained from examination of the ICP record, but in all three patients the device subsequently under-read, the true ICP only becoming evident during infusion tests. Table 3 compares the infusion test category with the duration of monitoring. It can be seen that leakage around the device, over-reading due to local hematoma formation, and pocketing around the device are predominantly early problems occurring within the first 4 days, whereas obstruction of the device itself and plateauing occur at any stage of monitoring. Similarly, while the majority of normal infusion tests occur during the first 3 days, the percentage of normal infusion tests per day varies little throughout the 10-day period, re- Table 2 . ICP = intracranial pressure. The results shown in Table 4 indicate that there was no statistically significant difference in mean ICP between normal (Category 1) and partial obstruction infusion tests where the partial obstruction had only altered amplitude (Category 2A). However, a highly statistically significant difference exists between the normal and the partially obstructed groups where both mean ICP and amplitude were affected (Category 2B). Similarly, the mean ICP from devices exhibiting plateauing (Category 4) was significantly greater than that of normally functioning devices. Figure 5 shows simultaneous independent recordings Table 2 . t Values are measured in mm Hg and are means _+ standard error of the means. Significance: :~ = p < 0.01; w = p < 0.001. of ventricular and subarachnoid space pressures using a ventricular catheter and Leeds device, respectively, in one patient. The figure compares the ICP's recorded after an infusion test (infusion period 1) had confirmed that the device, which was initially partially obstructed (infusion periods 1 and 2), was functioning normally. After infusion period 3, the two pressures varied by only 1 to 3 m m Hg, but the Leeds device tended to record slightly low. The effects on ICP of two bolus doses of Althesin (9 mg of alfaxalone and 3 mg of alfadolone per ml) are illustrated. After the first bolus, when the ICP was rising, two infusion tests were performed. It is important to note that the performance of the infusion test neither increased the slope of the rising ICP nor caused the device reading to exceed the ventricular pressure at any stage. These points indicate that at the slow rates of infusion used for these tests, there is no localized pressure rise around a device that is functioning well, nor is there a significant volume stress on the intracranial space. Similarly, flushing the device, as described above, did not produce any steep change in ICP.
Discussion
In Leeds, a surface subarachnoid device is used as the method of choice for ICP recording following severe head injury, because insertion is considerably easier than ventricular catheterization when the ventricles are compressed or displaced. Although some centers advocate removal of such devices at 48 hours to minimize the risk of infection, we monitor for up to 16 days, with an infection incidence below 2% in more than 200 cases. Although this method of ICP measurement gives high-quality recordings, with a rapid response time enabling trace amplitude analysis, the Leeds device may sometimes become obstructed. Detection and rectification of such obstruction is essential if correct readings are to be obtained. In the past, flushing a device has been thought to ensure free communication with the CSF, but Fig. 3 demonstrates that this is not always so. The infusion component of this test is necessary to confirm free communication with the CSF. The test showed that on many occasions the Leeds device was relaying inaccurate information (in 36 of 69 tests), but correction was possible in 31 of these 36 instances.
The majority of incorrect readings were due to intermittent obstruction. Surprisingly, obstruction was not related to the duration of monitoring, but it may be that daily infusion testing was prophylactic in avoiding obstruction. In this study, an elevated ICP seems to be a major factor correlating with obstruction. A possible method of preventing a recurring obstruction would be to continuously infuse the device with saline, as suggested by Baker and Bishara, ~ who infused a subdural catheter continuously with heparinized saline. They confirmed the correlation between subarachnoid surface pressure and intraventricular pressure recording, and reported good-quality recordings with their method. We wonder, however, whether continuous infusion might not sometimes produce a localized spaceoccupying lesion if the device were surrounded by a contused area of brain, and consider that repeated short infusions at 6-to 8-hour intervals provide a safer alternative, especially in patients with an elevated ICP.
The need to perform regular infusion tests to assess the accuracy of pressure monitoring is emphasized by the course of two patients from this series, who had infusion tests demonstrating that the Leeds device was obstructed. The post-flush infusion value for ICP was not within the normal range, as was being recorded before, but was over 20 mm Hg. As a result, computerized tomography (CT) scanning was repeated and in both patients revealed the presence of a subdural hematoma not evident on the admission CT scan. Neither patient had developed pupillary signs at the time of surgical decompression of these hematomas.
The time of supratentorial coning is not always evident from the ICP record, using the Leeds device. This is presumably because of obstruction of the device by swollen brain. The use of an infusion test to confirm that ICP has risen to the level of mean blood pressure is therefore of value as an additional test when coning is clinically suspected.
It is necessary to be sure that infusion testing and flushing do not themselves elevate ICP, either locally or globally. Several factors support the view that this does not occur. In patients with a normal pre-flush infusion the second infusion produces an identical pattern to the first, with no alteration in ICP or trace amplitude. Second, in patients with ICP values below 20 mm Hg, flushing the device with 0.2 ml saline, repeated up to four times, and allowing free drainage of fluid to minimize any change in CSF volume, produces either no change in ICP or an increase in amplitude with no alteration in mean ICP. Subsequent infusion or flushing produces no further changes in mean ICP or amplitude. These observations suggest that in patients with normal or low ICP, neither component of the infusion test significantly affects intracranial dynamics, and that any initial change in amplitude is probably due to relief of partial obstruction.
It is in patients with ICP elevated more than 20 mm Hg that any alteration in intracranial dynamics produced by the infusion test will be most obvious. In these patients, many of the recordings show a partially obstructed pattern, but after obstruction has been relieved by flushing, repeated infusion tests cause no further alteration in ICP or trace amplitude. Also, in one patient the infusions of saline at the rate used in this study did not increase local subarachnoid pressure above ventricular pressure (Fig. 5) .
The situation regarding flushing of a device at high ICP is not so clear. In patients with an obstructed pattern on the pre-flush infusion test, a 0.2-ml flush repeated up to four times occasionally produced a 2-to 3-mm Hg rise in ICP, when the ICP 1 minute after the flush was compared to the ICP immediately after flushing. This rise invariably settled within 30 seconds of flushing. However, if subsequent infusions of 0.02 ml of saline over 2 minutes confirmed that the obstruction had been relieved, a second 0.2-ml flush failed to produce further alteration in ICP or amplitude.
The rise in ICP described above may therefore represent a local phenomenon. Analysis of Fig. 5 supports this view, in that a 30-second elevation in subarachnoid space pressure followed a 0.2-ml flush of normal saline without affecting ventricular pressure. Nevertheless, Miller, et al., j7~19 regarded an increase of 2 mm Hg following injection of 1 ml of saline over 1 second into the ventricles as significant, so that, in the absence of ventricular pressure monitoring to confirm that the rise in pressure after flushing is a local phenomenon, a 2-minute period of stabilization following flushing is advisable to see if ICP settles to a lower level.
In conclusion, there have been few studies analyzing the reliability of surface subarachnoid measurement of ICP in man. The present study confirms the recent report of Mendelow, et aL, ~5 that subdural and subarachnoid screws may relay unreliable information and, in particular, may under-read high ICP's. The infusionflush-infusion sequence described here detects incorrect readings and improves the performance of such ICP systems.
